Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

SHSSX vs GGHCX overlap: 57% of top holdings shared

Bottom line

How much do SHSSX and GGHCX overlap?

57% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 49.8% of SHSSX's assets and 44.1% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

SHSSXGGHCX
Weight overlap (top 25)57%
Shared holdings10
Weight in shared holdings49.8%44.1%
Total positions15582
Expense ratio0.86%1.07%
Holdings as ofMay 29, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)

Holdings SHSSX and GGHCX have in common

Holding% of SHSSX% of GGHCXOverlap
Eli Lilly & Company LLY12.29%10.59%10.59%
Johnson & Johnson JNJ8.77%6.76%6.76%
Unitedhealth Group Inc UNH6.10%6.17%6.10%
Merck & Company Inc MRK4.94%4.59%4.59%
Gilead Sciences Inc GILD4.19%3.63%3.63%
Abbvie Inc ABBV3.94%4.03%3.94%
Thermo Fisher Scientific Inc TMO3.02%1.55%1.55%
Vertex Pharmaceuticals Inc VRTX2.74%2.01%2.01%
Edwards Lifesciences Corp EW2.51%1.56%1.56%
Argenx Se ARGX1.26%3.24%1.26%

Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in SHSSX

  1. Amgen Inc — 3.37%
  2. Pfizer Inc — 2.61%
  3. Danaher Corp — 2.00%
  4. Abbott Laboratories — 1.97%
  5. Intuitive Surgical Inc — 1.95%
  6. Teva Pharmaceutical Industries Ltd — 1.87%
  7. Boston Scientific Corp — 1.59%
  8. Elevance Health Inc — 1.56%
  9. Biogen Inc — 1.21%
  10. Astrazeneca Plc — 1.21%
  11. Stryker Corp — 1.15%
  12. Blackrock Funds III — 1.01%
  13. Revolution Medicines Inc — 0.96%
  14. Humana Inc — 0.92%
  15. Regeneron Pharmaceuticals Inc — 0.91%

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. CVS Health Corp. — 2.52%
  3. Welltower Inc. — 2.34%
  4. BrightSpring Health Services, Inc. — 2.20%
  5. Royalty Pharma PLC — 2.13%
  6. Cardinal Health, Inc. — 2.10%
  7. Guardant Health, Inc. — 2.04%
  8. Invesco Private Government Fund — 1.80%
  9. Axsome Therapeutics, Inc. — 1.58%
  10. Invesco Treasury Portfolio — 1.56%
  11. BridgeBio Pharma, Inc. — 1.43%
  12. Waters Corp. — 1.41%
  13. IQVIA Holdings Inc. — 1.32%
  14. U C B S.a. — 1.24%
  15. Ligand Pharmaceuticals Inc. — 1.18%

Asset mix

Asset typeSHSSXGGHCX
Stocks99.8%97.5%
Cash & short-term funds1.4%8.8%

Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)

Country mix

CountrySHSSXGGHCX
US93.9%93.5%
NL1.3%3.4%
GB1.4%3.1%
CH1.4%2.7%
IL1.9%0.4%
BE0.3%1.2%
DK—1.1%
IE—0.6%

Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do SHSSX and GGHCX overlap?
About 57% by weight. 10 securities appear in both funds' top 25 holdings; they make up 49.8% of SHSSX's assets and 44.1% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do SHSSX and GGHCX have in common?
The largest shared holdings are Eli Lilly & Company, Johnson & Johnson, Unitedhealth Group Inc, Merck & Company Inc, Abbvie Inc.
Should I own both SHSSX and GGHCX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, SHSSX or GGHCX?
SHSSX is broader, with 155 positions versus 82 for GGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.